Insider Trading Alert - CTSH, UDR, AKRX, PANW And H Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 11, 2013, 145 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $117.00 to $353,142,000.00.

Highlighted Stocks Traded by Insiders:

Cognizant Technology Solutions Corporation (CTSH) - FREE Research Report

Krishnaswamy Venkat who is EVP, Pres Healthcare & Life Sc at Cognizant Technology Solutions Corporation sold 754 shares at $95.76 on Dec. 11, 2013. Following this transaction, the EVP, Pres Healthcare & Life Sc owned 6,604 shares meaning that the stake was reduced by 10.25% with the 754-share transaction.

The shares most recently traded at $93.42, down $2.34, or 2.5% since the insider transaction. Historical insider transactions for Cognizant Technology Solutions Corporation go as follows:

  • 4-Week # shares sold: 31,149
  • 12-Week # shares sold: 48,902
  • 24-Week # shares bought: 7,500
  • 24-Week # shares sold: 153,164

The average volume for Cognizant Technology Solutions Corporation has been 1.9 million shares per day over the past 30 days. Cognizant Technology Solutions Corporation has a market cap of $28.6 billion and is part of the technology sector and computer software & services industry. Shares are up 26.55% year-to-date as of the close of trading on Wednesday.

Cognizant Technology Solutions Corporation provides information technology (IT), consulting, and business process outsourcing services worldwide. The company operates through four segments: Financial Services; Healthcare; Manufacturing, Retail, and Logistics; and Other. The company has a P/E ratio of 24.3. Currently there are 14 analysts that rate Cognizant Technology Solutions Corporation a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CTSH - FREE

TheStreet Quant Ratings rates Cognizant Technology Solutions Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Cognizant Technology Solutions Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

UDR (UDR) - FREE Research Report

Toomey Thomas W who is Chief Executive Officer at UDR sold 12,000 shares at $24.40 on Dec. 11, 2013. Following this transaction, the Chief Executive Officer owned 972,368 shares meaning that the stake was reduced by 1.22% with the 12,000-share transaction.

The shares most recently traded at $23.77, down $0.63, or 2.65% since the insider transaction. Historical insider transactions for UDR go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 17,000
  • 24-Week # shares sold: 79,000

The average volume for UDR has been 1.4 million shares per day over the past 30 days. UDR has a market cap of $6.1 billion and is part of the financial sector and real estate industry. Shares are up 2.61% year-to-date as of the close of trading on Wednesday.

UDR, Inc. is an independent real estate investment trust. The firm invests in the real estate markets of the United States. It owns, operates, acquires, renovates, develops, redevelops, and manages multifamily apartment communities. The stock currently has a dividend yield of 3.85%. Currently there are 3 analysts that rate UDR a buy, no analysts rate it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UDR - FREE

TheStreet Quant Ratings rates UDR as a hold. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, increase in net income and revenue growth. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow and poor profit margins. Get the full UDR Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Akorn (AKRX) - FREE Research Report

Weinstein Alan D who is Director at Akorn sold 20,000 shares at $25.52 on Dec. 11, 2013. Following this transaction, the Director owned 53,857 shares meaning that the stake was reduced by 27.08% with the 20,000-share transaction.

The shares most recently traded at $24.69, down $0.83, or 3.36% since the insider transaction. Historical insider transactions for Akorn go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares sold: 5,000

The average volume for Akorn has been 787,800 shares per day over the past 30 days. Akorn has a market cap of $2.4 billion and is part of the health care sector and drugs industry. Shares are up 86.68% year-to-date as of the close of trading on Wednesday.

Akorn, Inc. engages in the manufacture and marketing of diagnostic and therapeutic ophthalmic pharmaceuticals products, hospital drugs, and injectable pharmaceuticals in the United States and internationally. The company has a P/E ratio of 62.4. Currently there are 6 analysts that rate Akorn a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on AKRX - FREE

TheStreet Quant Ratings rates Akorn as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Akorn Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Palo Alto Networks (PANW) - FREE Research Report

Chandna Asheem who is Director at Palo Alto Networks sold 17,500 shares at $51.91 on Dec. 11, 2013. Following this transaction, the Director owned 116,598 shares meaning that the stake was reduced by 13.05% with the 17,500-share transaction.

Batra Rajiv who is VP, Engineering at Palo Alto Networks sold 10,000 shares at $52.50 on Dec. 11, 2013. Following this transaction, the VP, Engineering owned 170,050 shares meaning that the stake was reduced by 5.55% with the 10,000-share transaction.

Bonvanie Rene who is Chief Marketing Officer at Palo Alto Networks sold 37,500 shares at $52.00 on Dec. 11, 2013. Following this transaction, the Chief Marketing Officer owned 265,053 shares meaning that the stake was reduced by 12.39% with the 37,500-share transaction.

The shares most recently traded at $52.07, up $0.07, or 0.13% since the insider transaction.

The average volume for Palo Alto Networks has been 1.1 million shares per day over the past 30 days. Palo Alto Networks has a market cap of $3.8 billion and is part of the technology sector and computer hardware industry. Shares are down 2.84% year-to-date as of the close of trading on Wednesday.

Palo Alto Networks, Inc. offers a network security platform in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan. The company's platform comprises Next-Generation Firewall that delivers application, user, and content visibility and control. Currently there are 11 analysts that rate Palo Alto Networks a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PANW - FREE

TheStreet Quant Ratings rates Palo Alto Networks as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Palo Alto Networks Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Hyatt Hotels Corporation (H) - FREE Research Report

Webb Robert W.K. who is See Remarks at Hyatt Hotels Corporation sold 4,000 shares at $47.19 on Dec. 11, 2013. Following this transaction, the See Remarks owned 25,137 shares meaning that the stake was reduced by 13.73% with the 4,000-share transaction.

The shares most recently traded at $47.04, down $0.15, or 0.32% since the insider transaction. Historical insider transactions for Hyatt Hotels Corporation go as follows:

  • 4-Week # shares sold: 2,760
  • 12-Week # shares sold: 5,260
  • 24-Week # shares sold: 8,260

The average volume for Hyatt Hotels Corporation has been 315,300 shares per day over the past 30 days. Hyatt Hotels Corporation has a market cap of $2.1 billion and is part of the services sector and leisure industry. Shares are up 22.5% year-to-date as of the close of trading on Wednesday.

Hyatt Hotels Corporation, a hospitality company, manages, franchises, owns, and develops Hyatt-branded hotels, resorts, and residential and vacation ownership properties worldwide. As of September 30, 2013, its portfolio consisted of 535 properties in 47 countries. The company has a P/E ratio of 39.7. Currently there are 7 analysts that rate Hyatt Hotels Corporation a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on H - FREE

TheStreet Quant Ratings rates Hyatt Hotels Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Hyatt Hotels Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

50 Stocks Goldman Sachs Thinks Can Triumph Over Labor Inflation

50 Stocks Goldman Sachs Thinks Can Triumph Over Labor Inflation

Trump Issues New Trade Threats, Apple, ZTE, GameStop - 5 Things You Must Know

Trump Issues New Trade Threats, Apple, ZTE, GameStop - 5 Things You Must Know

China-Focused Stocks Hit Hard as Beijing Responds to Trump Tariff Threats

China-Focused Stocks Hit Hard as Beijing Responds to Trump Tariff Threats

Dow Futures Plunge, Global Markets Rocked as Trump Takes Trade War to Next Level

Dow Futures Plunge, Global Markets Rocked as Trump Takes Trade War to Next Level

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China